Synopsis
Guest hosts interview industry insiders on strategies, business models, leadership, technologies & innovations in advancing drug development for the benefit of patients. More specifically: clinical trials, patient-centricity, mobile/digital in R&D, drug delivery, emerging biotechs and Immuno-Oncology. PharmaTalkRadio is a non-profit program to provide easy and free access of helpful information for professionals in life sciences as well as patient advocates. It is organized and supported by the Conference Forum.
Episodes
-
Immuno-Oncology Debate 2024 on Solving Cancer’s Top Challenges
09/12/2024 Duration: 38minFor more information, visit theconferenceforum.org
-
CMO Misunderstandings about Clinical Operations and How to Improve
05/12/2024 Duration: 33minMany of the clinical trial delays and recruitment challenges in today's industry can be attributed to decisions made while designing the protocol and in the outsourcing strategy. Bringing clinical operations experts into the decision-making process can help proactively address some of the biggest challenges facing trials today. In this podcast, Raul Lima, MBA, EVP, Strategic Clinical Operations of inSeption Group, explains the difference between clinical development and clinical operations, misconceptions CMOs have about clinical operations and how to successfully navigate the complexities of clinical trial execution. For more information about inSeption Group, visit inSeptionGroup.com. For more information about the annual Chief Medical Officer Summit 360° and its affiliated editorials, podcasts and webcasts, please visit CMO360.org.
-
How Roche is Maximizing the Impact of Patient Insights in Early Development
03/12/2024 Duration: 19minFor more information, go to theconferenceforum.org
-
Designing and Developing Drug Delivery for Lower and Middle-Income Countries
21/11/2024 Duration: 42minThis podcast features a panel discussion on desgining and developing drug delivery and devices for LMICs with representatives from Gilead Sciences, the Bill & Melinda Gates Foundation, ApiJect and AbbVie From the 2024 PODD: Partnership Opportunities in Drug Delivery. The panelists discuss unique and compelling challenges of the last mile for LMICs, the role of pharma and medtech in the evolution of LMIC drug development, trends in the space, case studies of successful products and how to better consider cultural differences between LMICs and more developed markets. To learn more about the PODD conference, please visit PODDConference.com.
-
Clinical Research as Care Using Modern Software Infrastructure
19/11/2024 Duration: 26minFor more information, go to CRAACOevent.com or realtime-eclinical.com
-
Using Patient Insights Meaningfully throughout the Medicine & Disease Lifecycle
08/11/2024 Duration: 21minFor more information, visit theconferenceforum.org.
-
Innovative Approach for Elevating Patient-Centric Solutions in Pediatric Trials
08/11/2024 Duration: 16minFor more information, visit theconferenceforum.org
-
Incorporating Quantitative Values of Patient Perspectives into Trial Design
25/10/2024 Duration: 21minFor more information, visit theconferenceforum.org
-
Accessing a Novel Source of Patient Experience Data to Improve Clinical Research
24/10/2024 Duration: 17minFor more information, visit theconferenceforum.org
-
Empathy and Behavioral Science in ePROs to Increase Data Collection Adherence
23/10/2024 Duration: 24minFor more information, go to theconferenceforum.org
-
Antiviral Drug Development: Overcoming Challenges to the Current Model
11/10/2024 Duration: 28minAs viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed. In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug development and how NanoViricides developed a nanotechnology with a different approach to develop and deliver antiviral drugs. Anil also presents an overview of the scientific and clinical development of NanoViricides lead program, NV-387 as well as potential applications in different indications. For more information about NanoViricides Incorporated, visit NanoViricides.com. For more information about the annual PODD drug delivery conference, please visit Drug-Delivery.org.
-
Unlocking Pre-Enrollment Data to Help Sponsors Recruit and Enroll More Patients
09/10/2024 Duration: 21minFor more information, visit theconferenceforum.org
-
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care
09/10/2024 Duration: 36minFor more information, visit theconferenceforum.org
-
The History of Tumor Vaccines, and Why the Newest RNA Cancer Vaccines Might Work
07/10/2024 Duration: 23minFor more information, visit immuno-oncology360.org.
-
What Biotech CEOs Need to Know about Developing a Commercialization Roadmap
04/10/2024 Duration: 26minFor more information, visit theconferenceforum.org.
-
Simplicity in Technology Delivery for Clinical Trials
20/09/2024 Duration: 22minFor more information, visit theconferenceforum.org
-
Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral
19/09/2024 Duration: 29minTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.
-
Combining AI and Empirical Science to Advance Cancer Immunotherapies
13/09/2024 Duration: 25minFor more information, go to theconferenceforum.org
-
The Personal Impact of a Clinical Trial
12/09/2024 Duration: 20minFor more information, go to theconferenceforum.org
-
The Future of Patient-Centricity: Advancing Frameworks to Achieve Greater Impact
08/08/2024 Duration: 31minFor more information, visit patientsaspartners.org.